◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

AURINIA PHARMACEUTICALS INC.

CIK: 1600620 SIC: 2834
$283.06M
Revenue
$287.20M
Net Income
88.46%
Gross Margin
37.06%
Op. Margin
$182.50M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 7 of 15 quarterly reports available
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
+ Total Revenue $77.11M $73.47M $70.01M $62.47M $59.87M $67.77M $57.19M
Revenue Growth % (YoY) 28.8% 8.4% 22.4% nan% nan% nan% nan%
Cost of Revenue $8.80M $8.18M $7.12M $8.57M $5.55M $6.04M $8.91M
+ Gross Profit $68.31M $65.29M $62.89M $53.89M $54.31M $61.74M $48.28M
Gross Margin % 88.6% 88.9% 89.8% 86.3% 90.7% 91.1% 84.4%
Operating Expenses $43.88M $43.72M $49.92M $40.62M $61.54M $56.02M $58.70M
Research & Development $10.89M $8.44M $7.43M $5.74M $8.11M $3.05M $4.08M
+ Operating Income $33.24M $29.75M $20.08M $21.85M $-1.67M $11.75M $-1.51M
Operating Margin % 43.1% 40.5% 28.7% 35.0% -2.8% 17.3% -2.6%
Interest Expense $1.05M $1.10M $1.12M $1.07M $1.15M $1.21M $1.20M
Interest Income $3.50M $3.32M $3.19M $3.57M $3.99M $4.27M -
Income Before Tax $35.69M $31.96M $22.16M $24.35M $1.17M $14.81M $1.48M
Income Tax Expense $-175.10M $411.00K $643.00K $1.00M $-256.00K $457.00K $756.00K
+ Net Income $210.79M $31.55M $21.51M $23.34M $1.43M $14.35M $722.00K
Net Margin % 273.4% 42.9% 30.7% 37.4% 2.4% 21.2% 1.3%
Basic EPS 1.57 0.24 0.16 0.17 0.01 0.10 0.01
Diluted EPS 1.52 0.23 0.16 0.16 0.01 0.10 0.01
Basic Shares Outstanding - 131.8M 134.9M 138.9M -296K 143.1M 143.3M
Diluted Shares Outstanding - 136.0M 137.5M 143.2M 1.2M 145.7M 144.1M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Cash & Cash Equivalents $80.16M $72.89M $52.91M $66.11M $83.40M $36.63M $33.27M
Inventory $45.69M $44.79M $46.50M $46.20M $39.23M $38.71M $38.85M
Other Current Assets $1.08M $301.00K $665.00K $781.00K $1.13M $2.70M $6.98M
Total Current Assets $491.97M $438.74M $408.97M $405.76M $446.60M $440.46M $409.67M
Property Plant & Equipment $2.11M $2.27M $2.42M $2.58M $2.73M $2.89M $3.04M
Intangible Assets $3.76M $3.90M $4.05M $4.16M $4.36M $4.51M $4.62M
Other Non-current Assets $93.00K $93.00K $93.00K $823.00K $823.00K $868.00K $867.00K
Total Assets $751.59M $527.53M $502.56M $504.85M $550.64M $549.36M $523.53M
Accounts Payable $3.31M $2.21M $3.31M $4.22M $5.19M - -
Accrued Liabilities $66.62M $49.54M $49.70M $42.35M $64.97M - -
Deferred Revenue $3.72M $4.60M $5.50M $4.59M $11.00M $4.30M $4.37M
Other Current Liabilities $2.48M $2.50M $2.54M $1.70M $1.53M $1.59M $1.16M
Total Current Liabilities $93.72M $76.22M $78.27M $68.41M $97.76M $78.61M $76.90M
Other Non-current Liabilities $6.70M - - - $11.11M $10.84M $10.94M
Total Liabilities $170.26M $161.76M $167.26M $154.66M $173.17M $161.36M $158.91M
Retained Earnings $-649.37M $-860.16M $-891.71M $-913.23M $-936.57M $-938.00M $-952.35M
Total Stockholders Equity $581.33M $365.77M $335.30M $350.19M $377.48M $388.00M $364.62M
Total Liabilities & Equity $751.59M $527.53M $502.56M $504.85M $550.64M $549.36M $523.53M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Net Income $210.79M $31.55M $44.86M $23.34M $1.43M $4.32M $722.00K
Depreciation & Amortization $4.86M $14.59M $9.72M $4.86M $4.86M - -
Stock-based Compensation $6.73M $7.95M $2.03M $-3.41M $8.95M $22.65M $14.32M
Change in Receivables $10.73M $-5.82M $3.55M $3.81M $61.00K $12.39M $1.43M
Change in Inventory $897.00K $5.57M $7.28M $6.97M $514.00K $-991.00K $-852.00K
Change in Payables $1.10M $-2.97M $-1.88M $-974.00K $-3.69M - -
Operating Cash Flow $45.67M $89.99M $45.54M $1.30M $30.11M $14.27M $-2.75M
Purchases of Investments $182.03M $344.62M $237.41M $91.99M $84.69M $461.14M $318.13M
Investing Cash Flow $-36.76M $3.99M $17.76M $31.03M $39.22M $39.00K $10.61M
Stock Issued $355.00K $401.00K $401.00K - $381.00K - -
Stock Repurchased - $98.16M $89.48M $46.92M $21.80M $18.43M $18.43M
Financing Cash Flow $-1.89M $-104.22M $-93.73M $-49.34M $-23.05M $-26.05M $-23.32M
Net Change in Cash $7.02M $-10.24M $-30.43M $-17.00M $46.29M $-11.73M $-15.47M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $73.47M - $205.94M -
Cost of Revenue $8.18M - $23.87M -
Operating Expenses $43.72M - $134.27M -
Research & Development $8.44M - $21.61M -
Operating Income $29.75M - $71.67M -
Interest Expense $1.10M - $3.28M -
Interest Income $3.32M - $10.07M -
Income Before Tax $31.96M - $78.47M -
Income Tax Expense $411.00K - $2.06M -
Net Income $31.55M $722.00K $76.41M -
Basic EPS 0.24 - 0.57 -
Diluted EPS 0.23 - 0.55 -
Basic Shares Outstanding $131.81M - $135.16M -
Diluted Shares Outstanding $136.01M - $138.96M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $72.89M -
Inventory $44.79M $39.23M
Other Current Assets $301.00K $1.13M
Total Current Assets $438.74M $446.60M
Property Plant & Equipment $2.27M $2.73M
Intangible Assets $3.90M $4.36M
Other Non-current Assets $93.00K $823.00K
Total Assets $527.53M $550.64M
Accounts Payable $2.21M $5.19M
Accrued Liabilities $49.54M $64.97M
Deferred Revenue $4.60M $11.00M
Other Current Liabilities $2.50M $1.53M
Total Current Liabilities $76.22M $97.76M
Total Liabilities $161.76M $173.17M
Retained Earnings $-860.16M $-936.57M
Total Stockholders Equity $365.77M $377.48M
Total Liabilities & Equity $527.53M $550.64M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $31.55M $722.00K $76.41M -
Depreciation & Amortization - - $14.59M -
Stock-based Compensation - - $7.95M -
Change in Receivables - - $-5.82M -
Change in Inventory - - $5.57M -
Change in Payables - - $-2.97M -
Operating Cash Flow - - $89.99M -
Purchases of Investments - - $344.62M -
Investing Cash Flow - - $3.99M -
Stock Issued - - $401.00K -
Stock Repurchased - - $98.16M -
Financing Cash Flow - - $-104.22M -
Net Change in Cash - - $-10.24M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading news...
TRENDING
Loading...